Pre-market hot trades in US stocks: Taoping pre-market down 7.70%; Palantir Tech pre-market up 3.11%

Popular Pre-Market Trades in US Stocks Taoping is down 7.70% in pre-market trading, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Palantir Tech is up 3.11% in pre-market trading. Based on recent news, On February 2, Palantir plans to release its Q4 2025 financial report, with market expectations for revenue to reach $1.34 billion, a 62% year-on-year increase, and earnings per share expected to be $0.23, a 64.3% year-on-year increase. This expectation has driven the stock price up. On January 31, analysts had mixed opinions on Palantir, with one side optimistic about its leading position in AI, while the other side expressed concerns about its high valuation. Nevertheless, the market remains focused on the growth of its commercial business. On January 30, Palantir's stock price has increased by approximately 78% in 2025, and the options market anticipates that the stock price could fluctuate by up to 9% after the earnings report is released. The strong demand in the AI industry and government contracts support the stock price. Top Gainers in Pre-Market US Stocks Darkiris is up 206.31% in pre-market trading. Based on recent key news: On January 30, Darkiris reported a 27.3% revenue growth for FY 2025, reaching $10.08 million. This financial report indicates an improvement in the company's profitability, driving the stock price significantly higher. On January 30, Darkiris's total shareholders' equity was $6.78 million, demonstrating the company's solid financial condition and boosting investor confidence. On January 30, Darkiris's gross profit was $2.5 million, with a gross margin of 24.8%, further supporting the rise in stock price. The US stock market has seen increased volatility recently, and risks should be monitored. China Su Xuan Tang Pharmaceutical is up 134.84% in pre-market trading. Based on recent key news: On January 30, China Su Xuan Tang Pharmaceutical announced a 1-for-150 stock consolidation. This move will reduce the number of outstanding shares to approximately 957,960 and adjust all outstanding stock options and warrants. This news has attracted market attention, driving the stock price significantly higher. Source: GlobeNewswire On January 31, following the announcement of the stock consolidation, China Su Xuan Tang Pharmaceutical's stock price experienced a decline. The market has uncertainty regarding the stock performance post-consolidation, leading to price volatility. Source: GlobeNewswire The pharmaceutical industry has seen increased volatility recently, and policy changes should be monitored. VenHub Global is up 77.56% in pre-market trading, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation